6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01941732 (ClinicalTrials.gov)	November 2003	10/9/2013	Motor Response to Sildenafil in PD	Motor Response to Acute Challenge to Sildenafil in Parkinsons Disease	Parkinsons Disease;Erectile Dysfunction	Drug: Sildenafil	Bispebjerg Hospital	NULL	Completed	18 Years	80 Years	Male	8	Phase 4	Denmark
2	NCT02162979 (ClinicalTrials.gov)	February 2002	26/12/2007	Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease	A Double-Blind, Placebo-Controlled, Cross-Over Study of Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease	Parkinson's Disease	Drug: sildenafil;Drug: Placebo	Loma Linda University	NULL	Terminated	18 Years	80 Years	All	2	Phase 2	United States